Neuroblastoma screening at one year of age

The New England Journal of Medicine
Freimut H SchillingJoerg Michaelis

Abstract

Neuroblastoma is the second most common type of childhood tumor. It is not known whether screening for neuroblastoma at one year of age reduces the incidence of metastatic disease or mortality due to neuroblastoma. We offered urine screening for neuroblastoma at approximately one year of age to 2,581,188 children in 6 of 16 German states from 1995 to 2000. A total of 2,117,600 eligible children in the remaining states served as controls. We compared the two groups in terms of the incidence of disseminated disease and mortality from neuroblastoma. A total of 1,475,773 children (61.2 percent of those who were born between July 1, 1994, and October 31, 1999) underwent screening. In this group, neuroblastoma was detected by screening in 149 children, of whom 3 have died. Fifty-five children who had negative screening tests were subsequently given a diagnosis of neuroblastoma; 14 of these children have died. The screened group and children in the control area had a similar incidence of stage 4 neuroblastoma (3.7 cases per 100,000 screened children [95 percent confidence interval, 2.7 to 4.7] and 3.8 per 100,000 controls [95 percent confidence interval, 2.9 to 4.6]) and a similar rate of death among children with neuroblastoma (1.3 d...Continue Reading

References

Jan 1, 1990·Medical and Pediatric Oncology·Y HanawaA Tsunoda
Jan 1, 1989·Medical and Pediatric Oncology·T TakedaN Takasugi
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Treuner, F H Schilling
Jun 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P KaatschJ Michaelis
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B De BernardiM Carli
Jun 1, 1995·British Journal of Cancer·J EstèveJ Michaelis
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G M BrodeurF Hedborg
Aug 7, 1996·International Journal of Cancer. Journal International Du Cancer·F Bessho
Jan 1, 1996·Cancer Treatment and Research·A B Miller
May 16, 1997·International Journal of Cancer. Journal International Du Cancer·M NishiN Takasugi
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K YamamotoY Hayashi
Sep 24, 1999·Medical and Pediatric Oncology·W G WoodsB Lemieux
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K KawaY Tsuchida
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F BertholdJ Sander
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M Maris, K K Matthay
Jun 24, 2000·JAMA : the Journal of the American Medical Association·H G WelchS Woloshin
Apr 20, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C SpixJ Michaelis
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M LastowskaUNKNOWN United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group
Apr 5, 2002·The New England Journal of Medicine·William G WoodsBernard Lemieux

❮ Previous
Next ❯

Citations

Oct 26, 2007·Der Radiologe·N Becker
Apr 28, 2005·Der Urologe. Ausg. A·T Simon
Jun 23, 2006·Analytical and Bioanalytical Chemistry·Tomomi HasegawaTsutomu Masujima
Aug 19, 2007·Pediatric Surgery International·Eiso HiyamaMegu Ohtaki
Jun 29, 2011·Pediatric Surgery International·B KostyrkaRajendra Kumar
Sep 1, 2011·Cancer Causes & Control : CCC·Amy Moore, Daniel A Enquobahrie
Nov 8, 2011·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Michael S Lauer
May 26, 2005·Cancer Letters·Takeo TanakaTadashi Sawada
Apr 7, 2005·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·D Douglas Miller, Leslee J Shaw
Feb 1, 2003·Urology·H Ballentine Carter
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Nai Kong V Cheung, Brian H Kushner
Jan 27, 2010·Oncogene·I Janoueix-LeroseyO Delattre
Apr 5, 2002·The New England Journal of Medicine·George Cunningham
Sep 13, 2002·The New England Journal of Medicine·Sachiyo Suita
May 7, 2004·The New England Journal of Medicine·Yoshitaka Tsubono, Shigeru Hisamichi
Apr 5, 2002·The New England Journal of Medicine·William G WoodsBernard Lemieux
Mar 18, 2005·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Masaki NioYutaka Hayashi
Mar 20, 2010·International Journal of Epidemiology·Thomas HarderAnja Harder
Feb 22, 2012·Japanese Journal of Clinical Oncology·Tomoyuki Kawada
Aug 19, 2004·Journal of the National Cancer Institute·Miguel AlaminosManel Esteller
Aug 4, 2005·Journal of the National Cancer Institute·Lee SoderstromBernard Lemieux
Feb 14, 2008·Journal of the National Cancer Institute·H Gilbert WelchLisa M Schwartz
Sep 2, 2009·Journal of the National Cancer Institute·H Gilbert Welch, Peter C Albertsen
Apr 24, 2010·Journal of the National Cancer Institute·H Gilbert Welch, William C Black
May 26, 2010·Journal of the National Cancer Institute·David H Newman
Jan 25, 2003·Journal of Pediatric Hematology/oncology·William G Woods
Aug 6, 2005·BMJ : British Medical Journal·H Gilbert WelchLisa M Schwartz
May 29, 2004·Journal of Clinical Pathology·M A Dyer
Jul 26, 2011·Journal of Medical Case Reports·Saulat H FatimiAwais Ashfaq
Mar 16, 2012·OncoTargets and Therapy·Weili Sun, Shakeel Modak
Jan 24, 2003·AJR. American Journal of Roentgenology·Leonard Berlin
Jun 13, 2009·Future Oncology·André OberthuerMatthias Fischer
Feb 9, 2012·International Journal of Molecular Sciences·John A SandovalRobert J Hickey
Feb 25, 2014·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·H-H Dubben
Dec 2, 2014·Pediatric Clinics of North America·Meredith S Irwin, Julie R Park
Oct 22, 2014·Nature Reviews. Clinical Oncology·Garrett M Brodeur, Rochelle Bagatell
Jul 12, 2013·Population Health Metrics·Michael S Lauer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
William G WoodsB Lemieux
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Stéphane BarretteWilliam G Woods
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Stéphane BarretteWilliam G Woods
© 2022 Meta ULC. All rights reserved